NRSN NeuroSense Therapeutics
- 0.930
- +0.030+3.31%
- 0.937
- +0.008+0.82%
NeuroSense Therapeutics News
EFFECT: Others
424B3: Prospectus
F-1: Registration statement for securities of certain foreign private issuers
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
EFFECT: Others
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer (related to financial reporting)
Analysis
Price Target
No Data
No Data